Over the last decade, an unprecedented expansion in the field of nanomedicine has resulted in the development of new nanomaterials for diagnosis and therapy of various diseases such as cancer. This book covers the design, synthesis and applications of various functionally-hybridized nanomaterials for biomedical applications. It includes strategies for design and synthesis of hybrid nanomaterials, surface engineering of various nanoparticle-based hybrid nanosystems for cancer imaging and therapy, toxicity aspects of nanomaterials and the challenges in translation research of hybrid nanomaterials.
Table of Contents
Introduction/Preface. Epitaxial Growth Techniques for the Synthesis of Hybrid Nanostructures. Engineering of Core/Shell Structured Hybrid Nanoparticles. Engineering of Hybrid Nanoparticles by Self-assembly. Engineering of Mesoporous Silica-Based Hybrid Nanoparticles for Cancer Imaging. Engineering of Quantum Dot-Based Hybrid Nanoparticles for Multimodality Imaging. Engineering of Iron Oxide Nanoparticle-Based Hybrid System for Cancer Imaging. Engineering of Hybrid Upconversion Nanoparticles for Multimodality Imaging. Engineering of Carbon-based Hybrid Nanomaterials. Hybrid Nanomaterials Based on Peptide/protein-polymer Conjugates. Engineering of Nanoscale Metal Organic Frameworks for Cancer Theranostics. Engineering of RBC Membrane-camouflaged Hybrid Nanoparticles. Engineering of Porous Hybrid Nanoparticles for Drug/Gene Delivery. Engineering of Hybrid Nanoparticles for Photothermal Therapy. Hybrid Nanosystems for Photodynamic Therapy 16. Engineering of Hybrid Nanosystems for Chemotherapy. Engineering of Hybrid Nanostructures for Combined Cancer Therapy. Theranostic Hybrid Nanoparticles: Design, Synthesis and Applications. Engineering of Graphene-Based Hybrid Nanoparticles for Cancer Theranostics. Engineering of Porphysome Nanovesicles for Cancer Imaging and Therapy. In Vivo Cancer Targeted Imaging and Therapy with Hybrid Nanomaterials. Nanotoxicology. Pathway to Clinical Translation of Hybrid Nanomaterials.